Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indocyanine Green for Prostate Cancer Surgical Margins
NCT02260349Phase 3Withdrawn
- Sponsor
- CHU Saint-Etienne
- Start
- Apr 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of indocyanine green in prostate cancer (PCa), sponsored by CHU Saint-Etienne. Planned start Apr 2014; status: withdrawn.
02
Drugs
indocyanine green
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02260349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260349.